Pharmaceutical Technology

DECEMBER 4, 2022

Humira is indicated for 10 adult and pediatric conditions, including Crohn’s disease, rheumatoid arthritis, and ulcerative colitis, as per its label. Samsung Bioepis and Organon previously stated that Hadlima's interchangeability data should be ready in 2024.

Biosimilars 104

Biosimilars Labelling Communication Hospitals 104

Pharmaceutical Technology

JANUARY 6, 2023

In September, Novartis sent the FDA a petition, after a similar one was rejected in April 2021, asking for Entresto’s patent protection to be extended to February 2024. Novartis argued that the early release of Entresto generics could cause labelling inconsistencies.

Documentation 97

Documentation Hospitals Dosage Drug Pricing 97

Pharmaceutical Technology

APRIL 24, 2023

Since then, the drug has been used off-label in breast cancer and other types of cancer. GlobalData predicts that Comirnaty’s sales will increase by more than 20% between 2024 and 2027. However, after a period of slow movement in the field, the FDA approved the first nanodrug, Doxil, for Kaposi sarcoma in 1995.

Vaccines 59

Vaccines Immunity Immunization Medical Schools 59